Idiopathic pulmonary haemosiderosis in paediatric patients: how to make an early diagnosis

Luca Castellazzi1, Maria Francesca Patria1, Gemma Frati1

  • 1Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122, Milan, Italy.

Insights

Idiopathic pulmonary haemosiderosis (IPH) in children can present without classic symptoms like coughing up blood. Early diagnosis of IPH is crucial for timely immunosuppressive treatment and improved outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Immunology

Background:

  • Idiopathic pulmonary haemosiderosis (IPH) is a rare, potentially fatal pediatric immune-mediated disorder.
  • Pathogenesis remains largely unknown, complicating early diagnosis.
  • Classical symptoms (hemoptysis, anemia, consolidation) are often absent initially.

Observation:

  • A 4-year-old girl presented with recurrent respiratory infections and severe anemia, unresponsive to iron therapy.
  • Computed tomography revealed ground-glass opacities suggestive of pulmonary hemorrhage.
  • Diagnosis of IPH was confirmed via siderophages in bronchoalveolar lavage after excluding other causes.

Findings:

  • IPH diagnosis should be considered in children with recurrent respiratory infections and unexplained iron-deficiency anemia.
  • Absence of hemoptysis does not rule out IPH in pediatric cases.
  • Prompt diagnosis enables initiation of immunosuppressive corticosteroid therapy.

Implications:

  • Highlights the importance of considering IPH in atypical presentations.
  • Emphasizes the need for early diagnosis to prevent severe outcomes.
  • Supports the use of immunosuppressive therapy for pediatric IPH.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
766
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312